Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Epoetin Alfa in Anemia in chronic kidney disease: NCT07565701 Clinical Landscape Report 2026
15 October 2026
NCT07565701 clinical landscape for Anemia in chronic kidney disease: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
HRS-9821 in Pulmonary Disease, Chronic Obstructive: NCT07567872 Clinical Landscape Report 2026
15 October 2026
NCT07567872 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Enzalutamide in Metastatic castration-resistant prostate cancer: NCT07570979 Clinical Landscape Report 2026
15 October 2026
NCT07570979 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Pentoxifylline in Chronic Kidney Diseases: NCT07561801 Clinical Landscape Report 2026
15 October 2026
NCT07561801 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GDC-1261 in Advanced Prostate Carcinoma: NCT07567846 Clinical Landscape Report 2026
15 October 2026
NCT07567846 clinical landscape for Advanced Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ERW316 in Advanced Malignant Solid Neoplasm: NCT07570966 Clinical Landscape Report 2026
15 October 2026
NCT07570966 clinical landscape for Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Glutathione in Chronic Kidney Diseases: NCT07572890 Clinical Landscape Report 2026
15 October 2026
NCT07572890 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fluciclovine 18F in Prostatic Cancer: NCT07569926 Clinical Landscape Report 2026
15 October 2026
NCT07569926 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ensifentrine in Pulmonary Disease, Chronic Obstructive: CTRI/2026/05/110142 Clinical Landscape Report 2026
15 October 2026
CTRI/2026/05/110142 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
DopaCell (Royan Institute) in Parkinson Disease: NCT07572071 Clinical Landscape Report 2026
15 October 2026
NCT07572071 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tadalafil in Urinary Incontinence: NCT07576335 Clinical Landscape Report 2026
15 October 2026
NCT07576335 clinical landscape for Urinary Incontinence: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Amoxicillin Trihydrate in Pulmonary Disease, Chronic Obstructive: NCT07574879 Clinical Landscape Report 2026
15 October 2026
NCT07574879 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…